InvestorsHub Logo
Followers 11
Posts 878
Boards Moderated 0
Alias Born 05/30/2013

Re: None

Wednesday, 12/14/2016 2:42:20 PM

Wednesday, December 14, 2016 2:42:20 PM

Post# of 130819

"Improper Testimony (FRE 701, 702, or 703, or Daubert v.
Merrell Dow Pharms., Inc., 509 U.S. 579 (1993)):
Paragraphs 18 and 34 of the exhibit include opinions that are
not based on sufficient facts or data, and do not reliably
apply facts and data using scientific principles in reaching
their conclusions."


"Relevance and Mischaracterizes the Document (FRE 401,
402, 403):
Paragraphs 23-25, and 48 mischaracterize Ex. 1001 (‘005
patent) and provide misleading arguments. Paragraphs 36-
38, 41-43, 45, 48 and 49 mischaracterize Ex. 1006 (Chu
‘684) and provide misleading arguments. Paragraph 48
mischaracterizes Exs. 1007 & 1008 (Chu ‘366 and Chen,
respectively) and provides misleading arguments."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VPLM News